Daniel M. Bradbury - Chairman of the Board and Chief Executive Officer @ Equillium

Start Free Trial

Pricing

Overview

Number of Portfolio Companies

Number of Current Board & Advisor Roles

Primary Job Title Chairman of the Board and Chief Executive Officer
Primary Organization
Equillium

Location San Diego, California, United States
Regions Greater San Diego Area, West Coast, Western US
Gender Male

Investor Type
obfuscated
obfuscation

LinkedIn View on LinkedIn

Daniel M. Bradbury is Director at Liquid Grids.

Personal Investments

Number of Investments

Daniel M. Bradbury

invested in

Alume Biosciences

obfuscation

. This investment -

Series A - Alume Biosciences

- was valued at

obfuscation

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Alume Biosciences	—	Series A - Alume Biosciences	obfuscated obfuscation

Partner Investments

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Amplo Biotechnology	BioBrit	Yes	Seed Round - Amplo Biotechnology	obfuscated obfuscation

Jobs

Number of Current Jobs

Daniel M. Bradbury

has

current jobs including

Director

Alume Biosciences

Executive Chairman

Equillium

, and

Director

Synedgen

Alume Biosciences DirectorMay 2020
Equillium Executive ChairmanJan 2020
Synedgen DirectorOct 2019
IQHQ DirectorOct 2019
Equillium Chairman of the Board and Chief Executive OfficerMay 2017
Intercept Pharmaceuticals DirectorJul 2016
Sensulin Executive ChairmanMay 2014
ProSciento DirectorNov 2013
Biocon DirectorJan 2013
BioBrit Managing MemberSep 2012

Board and Advisor Roles

Number of Current Board & Advisor Roles

Number of Past Board & Advisor Roles

Daniel M. Bradbury

holds

board and advisor roles including

Board Member

Amplo Biotechnology

Chairman Of The Board

Biolinq

, and

Chairman of the Board

Liquid Grids

Amplo Biotechnology Board MemberOct 2021
Biolinq Chairman Of The BoardNov 2017
Liquid Grids Chairman of the BoardMar 2014
Riecken Communities Libraries Member of the BoardMar 2014
Sensulin Advisory BoardJul 2013
Castle Biosciences Chairman of the Board2012
Rady School of Management Advisory Board Member2008
Rady School of Management Advisory Board Member2008
Amylin Pharmaceuticals President & Chief Executive Officer & DirectorMar 2007
Geron Board of Directors

Organization Name	Title At Company	Start Date	End Date
SmithKline Beecham Pharmaceuticals (SB)	Marketing & Sales Roles	—	—

Related Hubs

Hub Name	CB Rank (Hub)
Alumni Ventures Portfolio Companies	49,150
West Coast Biotechnology Companies	14,047
West Coast Public Companies With Less Than $1B in Revenue	30,374
Biopharma Public Companies With More Than $10M in Revenue	51,164
ADAR1 Capital Management Portfolio Companies	95,998
Biotechnology Public Companies	11,683
Companies that Went Public in 2018	31,119
Decheng Capital Portfolio Companies	81,925
West Coast Public Companies With More Than $10M in Revenue	19,549
Greater San Diego Area Biotechnology Companies	32,042